Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Director comp.
|
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/12/2022 |
4
| VEDANTA PARTNERS, LLC (10% Owner) has filed a Form 4 on REVIVA PHARMACEUTICALS HOLDINGS, INC.
Txns:
| Bought 869,565 options to buy
@ $0.0001, valued at
$87 Bought 513,834 options to buy
@ $0.0001, valued at
$51.4 Bought 869,565 warrants
@ $2.4, valued at
$2.1M
Bought 513,834 warrants
@ $2.4, valued at
$1.2M
|
|
06/30/2022 |
4
| Narayan Prabhu (CFO) has filed a Form 4 on REVIVA PHARMACEUTICALS HOLDINGS, INC.
Txns:
| Bought 50,000 shares
@ $1.2134, valued at
$60.7k
|
|
12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/10/2021 |
4
| Patel Purav (Director) has filed a Form 4 on REVIVA PHARMACEUTICALS HOLDINGS, INC.
Txns:
| Granted 5,300 options to buy
@ $3.78, valued at
$20k
|
|
12/10/2021 |
4
| Margolin Richard A (Director) has filed a Form 4 on REVIVA PHARMACEUTICALS HOLDINGS, INC.
Txns:
| Granted 5,300 options to buy
@ $3.78, valued at
$20k
|
|
12/10/2021 |
4
| Funtleyder Leslie D. (Director) has filed a Form 4 on REVIVA PHARMACEUTICALS HOLDINGS, INC.
Txns:
| Granted 5,300 options to buy
@ $3.78, valued at
$20k
|
|
06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2021 |
4
| Patel Purav (Director) has filed a Form 4 on REVIVA PHARMACEUTICALS HOLDINGS, INC.
Txns:
| Granted 4,000 options to buy
@ $4.73, valued at
$18.9k
|
|
06/16/2021 |
4
| Margolin Richard A (Director) has filed a Form 4 on REVIVA PHARMACEUTICALS HOLDINGS, INC.
Txns:
| Granted 4,000 options to buy
@ $4.73, valued at
$18.9k
|
|
06/16/2021 |
4
| Funtleyder Leslie D. (Director) has filed a Form 4 on REVIVA PHARMACEUTICALS HOLDINGS, INC.
Txns:
| Granted 4,000 options to buy
@ $4.73, valued at
$18.9k
|
|
06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/15/2021 |
4
| Narayan Prabhu (CFO) has filed a Form 4 on REVIVA PHARMACEUTICALS HOLDINGS, INC.
Txns:
| Granted 50,000 options to buy
@ $4.3, valued at
$215k
|
|
04/15/2021 |
4
| Patel Purav (Director) has filed a Form 4 on REVIVA PHARMACEUTICALS HOLDINGS, INC.
Txns:
| Granted 15,227 options to buy
@ $4.3, valued at
$65.5k
|
|
12/28/2020 |
4
| Tenzing LLC (10% Owner) has filed a Form 4 on REVIVA PHARMACEUTICALS HOLDINGS, INC.
Txns:
| Disposed of 540,500 warrants
@ $0 |
|
12/28/2020 |
4
| Tenzing LLC (10% Owner) has filed a Form 4 on REVIVA PHARMACEUTICALS HOLDINGS, INC.
Txns:
| Granted 197,500 shares
@ $0 Acquired 343,000 warrants
@ $0 Granted 197,500 warrants
@ $0 |
|
12/10/2020 |
4
| GLAZER CAPITAL, LLC (10% Owner) has filed a Form 4 on Tenzing Acquisition Corp.
Txns:
| Sold 367,000 shares
@ $10.88, valued at
$4M
|
|
12/09/2020 |
4
| GLAZER CAPITAL, LLC (10% Owner) has filed a Form 4 on Tenzing Acquisition Corp.
Txns:
| Disposed of 606,360 shares
@ $10.88, valued at
$6.6M
|
|
12/09/2020 |
4
| Hudson Bay Capital Management LP (10% Owner) has filed a Form 4 on Tenzing Acquisition Corp.
Txns:
| Sold 50,000 shares
@ $11.51, valued at
$575.5k
Disposed of 710,000 shares
@ $10.88, valued at
$7.7M
|
|
12/04/2020 |
4
| GLAZER CAPITAL, LLC (10% Owner) has filed a Form 4 on Tenzing Acquisition Corp.
Txns:
| Sold 261 shares
@ $11, valued at
$2.9k
|
|
12/01/2020 |
4
| GLAZER CAPITAL, LLC (10% Owner) has filed a Form 4 on Tenzing Acquisition Corp.
Txns:
| Sold 5,969 shares
@ $10.9, valued at
$65.1k
Sold 5,362 shares
@ $11, valued at
$59k
|
|
11/25/2020 |
4
| GLAZER CAPITAL, LLC (10% Owner) has filed a Form 4 on Tenzing Acquisition Corp.
Txns:
| Sold 23,611 shares
@ $10.9, valued at
$257.4k
Sold 7,103 shares
@ $10.9, valued at
$77.4k
|
|
11/18/2020 |
4
| GLAZER CAPITAL, LLC (10% Owner) has filed a Form 4 on Tenzing Acquisition Corp.
Txns:
| Sold 305 shares
@ $10.9, valued at
$3.3k
Sold 127 shares
@ $10.9, valued at
$1.4k
Sold 896 shares
@ $10.9, valued at
$9.8k
|
|
11/13/2020 |
4
| GLAZER CAPITAL, LLC (10% Owner) has filed a Form 4 on Tenzing Acquisition Corp.
Txns:
| Sold 5 shares
@ $10.9, valued at
$54.5 |
|
11/10/2020 |
4
| GLAZER CAPITAL, LLC (10% Owner) has filed a Form 4 on Tenzing Acquisition Corp.
Txns:
| Sold 1 shares
@ $10.9, valued at
$10.9 |
|
11/04/2020 |
4
| GLAZER CAPITAL, LLC (10% Owner) has filed a Form 4 on Tenzing Acquisition Corp.
Txns:
| Sold 1 shares
@ $11.5, valued at
$11.5 Sold 57,616 shares
@ $10.85, valued at
$625.1k
|
|
11/03/2020 |
4
| Hudson Bay Capital Management LP (10% Owner) has filed a Form 4 on Tenzing Acquisition Corp.
Txns:
| Bought 10,000 shares
@ $10.37, valued at
$103.7k
Sold 50,000 shares
@ $10.87, valued at
$543.5k
|
|
|
|
|